Found vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

MEDVi beats Found overall, scoring 7.7/10 vs 7.3/10. Found is more affordable at $264/mo vs $299/mo. Choose Found for users who want a science-backed weight loss program with beh. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side comparison of Found and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.

Found

#37 of 48

7.3/10

Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.

Visit Found

Higher Rated

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	Found	MEDVi
Our Score	7.3/10	7.7/10
Starting Price	$264/mo	$299/mo
Medication Type	Both	Both
Insurance Accepted	Yes	No
Best For	Users who want a science-backed weight loss program with behavior change support	Users who want a low entry price with oral and injectable compounded options
Ranking	#37	#22

Pros & Cons Compared

Found

Pros

+Active insurance coordination — Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
+10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill) — the widest formulary of any platform
+Typical insured copay of ~$30/mo for most members — dramatically lower than cash-pay alternatives
+Most members start treatment within one week of completing the health questionnaire

Cons

−Pricing is less transparent than flat-rate competitors — costs vary by insurance status and medication choice
−The insurance navigation process adds steps and complexity compared to simple cash-pay platforms
−Compounded medication availability may shift with FDA enforcement changes

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

MEDVi edges out Found with a score of 7.7/10 vs 7.3/10. If budget is your priority, Found starts at $264/mo compared to MEDVi's $299/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Found if you want: users who want a science-backed weight loss program with behavior change support. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Found nor MEDVi feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review